RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance.
Identification and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
胰腺导管腺癌(PDAC)是全球最致命的癌症之一。具有胶原结构的巨噬细胞受体(MARCO),一种表达于巨噬细胞表面的A类清道夫受体蛋白,在PDAC进展中的作用仍不清楚。
在此,我们鉴定出一个表达MARCO的巨噬细胞亚群,其具有强烈的免疫抑制特征,在PDAC患者中显著增多。对MARCO hi PDAC样本的分析显示,CD8⁺ T细胞和NK细胞比例降低,同时调节性T细胞(Tregs)比例升高。在体外,与多种PDAC细胞系共培养可有效诱导人和小鼠巨噬细胞上MARCO的表达,驱动其向促肿瘤极化表型转变。细胞间相互作用分析进一步表明,血管内皮生长因子(VEGF)选择性靶向MARCO⁺巨噬细胞,且VEGF刺激在体外显著上调MARCO表达。
值得注意的是,Marco的基因敲除在小鼠PDAC模型中显著抑制了肿瘤生长,至少部分是通过增加NK细胞和T细胞的比例实现的。
此外,MARCO⁺巨噬细胞在多种其他癌症类型中 also 富集,提示其潜在的泛癌相关性。总之,我们的发现揭示了MARCO⁺巨噬细胞在PDAC进展中的关键作用,并强调MARCO是一个有前景的治疗靶点,具有跨多种恶性肿瘤应用的潜力。
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide. The role of macrophage receptor with collagenous structure (MARCO), a scavenger receptor class-A protein expressed on macrophage surface, in PDAC progression remains unclear.
Here, we identified a subset of MARCO-expressing macrophages with strong immunosuppressive signatures that were markedly increased in PDAC patients. Analysis of MARCO hi PDAC samples displayed reduced proportion of CD8⁺ T cells and NK cells, accompanied by an increased proportion of regulatory T cells (Tregs).
In vitro, co-culture with multiple PDAC cell lines potently induced MARCO expression on both human and murine macrophages, driving them to a pro-tumorigenic polarization phenotype. Cell-cell interaction analyses further indicated that vascular endothelial growth factor (VEGF) selectively targets MARCO⁺ macrophages, and VEGF stimulation significantly upregulates MARCO expression in vitro.
Notably, genetic ablation of Marco markedly suppressed tumor growth in a murine PDAC model, at least partly through enhanced proportion of NK and T cells.
Furthermore, MARCO⁺ macrophages were also enriched across several other cancer types, suggesting a potential pan-cancer relevance. Collectively, our findings uncover a critical role of MARCO⁺ macrophages in PDAC progression and highlight MARCO as a promising therapeutic target with potential applicability across multiple malignancies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。